Invesco Pharmaceuticals ETF (PJP) Dividend Yield, History & Forecast

Invesco Pharmaceuticals ETF (PJP) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 0.86% ($1.13 per share annually (TTM)). The most recent ex-dividend date was September 21, 2026, with payment scheduled for September 25, 2026. market capitalization is approximately $379M. Review PJP dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

PJP fund composition

PJP holds 28 positions, with 52.0% of assets in its ten largest. It charges an expense ratio of 0.58%, and manages $579.3M.

Top 10 holdings

HoldingWeight
GILDGilead Sciences Inc6.14%
LLYEli Lilly & Co6.13%
ABBVAbbVie Inc5.86%
PFEPfizer Inc5.75%
AMGNAmgen Inc5.63%
JNJJohnson & Johnson5.31%
ABTAbbott Laboratories5.11%
MRKMerck & Co Inc5.08%
REGNRegeneron Pharmaceuticals Inc3.52%
UTHRUnited Therapeutics Corp3.51%

Sector allocation

Healthcare100.0%Financial Services0.3%

Frequently Asked Questions about Invesco Pharmaceuticals ETF (PJP)

What is Invesco Pharmaceuticals ETF's dividend yield?
Invesco Pharmaceuticals ETF (PJP) pays a current trailing twelve-month dividend yield of 0.86%, which works out to $1.13 per share annually based on the most recent payout schedule.
When does Invesco Pharmaceuticals ETF pay distributions?
The most recent ex-dividend date was September 21, 2026. The next scheduled dividend payment date is September 25, 2026.
How many years has Invesco Pharmaceuticals ETF increased its dividend?
Invesco Pharmaceuticals ETF (PJP) has increased its dividend for 8 consecutive years.
What does Invesco Pharmaceuticals ETF invest in?
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of common stocks of 30 U.S. pharmaceutical companies. These companies are engaged principally in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The fund is non-diversified.